GUMM - Eliminate the Common Cold Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: StockDung	7/29/2012 5:35:47 PM
	1 Recommendation of 5582

Zicam Maker Coughs Up $4.5M to Settle Shareholder Action By Gavin Broady Law360, New York (July 27, 2012, 7:42 PM ET) -- Matrixx Initiatives Inc., maker of the cold remedy Zicam, has agreed to pay $4.5 million to settle an eight-year-old class action alleging the company violated securities laws by concealing reports that the medication may cause a permanent loss of the sense of smell, according to documents filed in Arizona federal court Friday. Matrixx and lead plaintiff NECA-IBEW Pension Fund have reached an accord that would bring an end to a long-running suit that traveled all the way up to the U.S. Supreme Court before being remanded... law360.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next